Artwork

Content provided by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Weekend Watchlist - BIOGEN

11:26
 
Share
 

Manage episode 291972199 series 2667578
Content provided by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to this first episode of Weekend Watchlist. These episodes are designed to take a deep dive into a company and why it might be worth putting on your watch list. It's not a recommendation to buy, but a way of learning how the experts go about screening for value.


Ethan Widell Senior Analyst from Ironhold Capital joined me to discuss BIOGEN (BIIB) a pharmaceutical company that has had its stock price punished after a negative patent outcome. There is an upside due to a new Alzheimers drug due for approval in June.


“It's trading as though investors think there's a 100% chance of it being rejected. It's about fair value given very, very negative assumptions about the company. So our thoughts are that it remains a great company, regardless of whether it can pass this through. And while it has some bumpy years ahead with that loss of its major drug, it still has a great niche and still has a great ability to produce more drugs in the future.”


Simply Wall St data: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen


Click here to find out more about Ironhold Capital https://www.ironholdcapital.com/home


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITIES MENTIONED IN THIS EPISODE. THESE ARE IDEAS TO CONSIDER FOR PUTTING ON YOUR WATCHLIST AND LEARNING MORE ABOUT HOW COMPANIES ARE VALUED


Portfolio tracker Sharesight tracks your trades, shows your true performance, and saves you time and money at tax time. Get 4 months free at https://www.sharesight.com/au/sharesforbeginners

Disclosure: The links provided are affiliate links. I will be paid a commission if you use these link to make a purchase. You will also usually receive a discount by using these links/coupon codes. I only recommend products and services that I use and trust myself or where I have interviewed and/or met the founders and have assured myself that they’re offering something of value.

Stocks for Beginners is for information and educational purposes only. It isn’t financial advice, and you shouldn’t buy or sell any investments based on what you’ve heard here. Any opinion or commentary is the view of the speaker only not Stocks for Beginners. This podcast doesn’t replace professional advice regarding your personal financial needs, circumstances or current situation.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

202 episodes

Artwork

Weekend Watchlist - BIOGEN

Stocks for Beginners

58 subscribers

published

iconShare
 
Manage episode 291972199 series 2667578
Content provided by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip Muscatello and Philip Muscatello - Investment Education for the Stock Market or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to this first episode of Weekend Watchlist. These episodes are designed to take a deep dive into a company and why it might be worth putting on your watch list. It's not a recommendation to buy, but a way of learning how the experts go about screening for value.


Ethan Widell Senior Analyst from Ironhold Capital joined me to discuss BIOGEN (BIIB) a pharmaceutical company that has had its stock price punished after a negative patent outcome. There is an upside due to a new Alzheimers drug due for approval in June.


“It's trading as though investors think there's a 100% chance of it being rejected. It's about fair value given very, very negative assumptions about the company. So our thoughts are that it remains a great company, regardless of whether it can pass this through. And while it has some bumpy years ahead with that loss of its major drug, it still has a great niche and still has a great ability to produce more drugs in the future.”


Simply Wall St data: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen


Click here to find out more about Ironhold Capital https://www.ironholdcapital.com/home


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITIES MENTIONED IN THIS EPISODE. THESE ARE IDEAS TO CONSIDER FOR PUTTING ON YOUR WATCHLIST AND LEARNING MORE ABOUT HOW COMPANIES ARE VALUED


Portfolio tracker Sharesight tracks your trades, shows your true performance, and saves you time and money at tax time. Get 4 months free at https://www.sharesight.com/au/sharesforbeginners

Disclosure: The links provided are affiliate links. I will be paid a commission if you use these link to make a purchase. You will also usually receive a discount by using these links/coupon codes. I only recommend products and services that I use and trust myself or where I have interviewed and/or met the founders and have assured myself that they’re offering something of value.

Stocks for Beginners is for information and educational purposes only. It isn’t financial advice, and you shouldn’t buy or sell any investments based on what you’ve heard here. Any opinion or commentary is the view of the speaker only not Stocks for Beginners. This podcast doesn’t replace professional advice regarding your personal financial needs, circumstances or current situation.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

202 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide